Answers are grounded in this paper and cite their sources.
Research investigates hyperacute rejection in kidney transplants, indicating severe implications for transplant success.
Hyperacute rejection represents one of the most catastrophic forms of kidney allograft failure, typically driven by preformed donor-specific antibodies targeting human leukocyte antigen (HLA) or ABO blood group antigens.1-3 With routine pretransplant anti-HLA antibody screening and lymphocyte crossmatch testing, the incidence of hyperacute rejection has markedly declined.4-6 Nevertheless, its occurrence in ABO-compatible and lymphocyte crossmatch negative recipients remains an alarming clinical scenario.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: